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INTRODUCTION 
Ever since 1948, when Corcoran and Page introduced their method 
for the determinations of plasma steroids (17) many workers have 
directed their efforts to the perfection of steroid analysis and 
the correlation of physiological effects with plasma steroid levels 
under clinical and experimental conditions. Important methodological 
advances have been made since that time. Much effort has been di¬ 
rected to the analysis of free hydrocortisone in the plasma, because 
many workers have shown that this is the predominant glucocorticoid 
secreted by the human adrenal gland (l4,27,48,57)• Methods for this 
analysis have been as numerous as laboratories conducting research 
in the field. Significant advances were recorded by Porter and 
Silber (4o), whose quantitative color reaction with phenylhydrazine 
hydrochloride was adopted by many workers, and which, with modifica¬ 
tions, is still the basis of some methods. Nelson and Samuels (34), 
Bush (13), Morris and Williams (33)> Bondy and Altrock (8), Kassenaar 
et al. (28), and Weichselbaum et al. (63), to mention just a few, 
all found it necessary to process plasma by extraction followed by 
purification of the extract and use the Porter-Silber or other re¬ 
actions for quantitation of the purified substance. Most of these 
methods are time consuming, intricate procedures involving numerous 
steps with various solvents and precipitates for extraction, usually 
followed by column chromatography for purification. Bush (13) has 
purified the extract with paper chromatography. Only recently 
Wallace et al. (62) published a simplified method well suited to 
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clinical work but at the expense of the high degree of accuracy needed 
for experimentation. The method of Nelson and Samuels has been the 
most widely used procedure up to the present time. Recently Bondy et 
al. (7) have used a method involving paper chromatography for puri¬ 
fication of a chloroform extract of plasma. The main advantage of 
this method lies in the fact that the extraction procedure is simple 
and relatively pure hydrocortisone can be isolated on paper,, free from 
the contaminants usually added by columns, and separated from other 
steroids that might run in the hydrocortisone fraction. 
Because of the very low concentrations of plasma steroids their 
quantitation has been a challanging problem. Methods introduced by 
Corcoran and Page (17) depend on the presence of the ketol side 
chain, as does the Porter Silber phenylhydrazine hydrochloride re¬ 
action (40). Bush (13) quantitated his paper spots by their reac¬ 
tion with iodine. Recently methods that use the fluorescent proper¬ 
ties of ^ 4-3-ketosteroids in acid or alkaline solutions have been 
developed for the accurate determination of small amounts of purified , 
steroids (l,55)- The advantage of these procedures is that results 
are readily reproducible at low concentrations, and they are specific 
V 
for those steroids which have the £ 4-3-configuration in ring A. 
Since the advent of improved methods many studies have been 
done to determine the fate of hydrocortisone and correlate plasma 
levels with metabolic effects in normal humans and persons under 
various clinical and test situations (2,24,29,31;37;39;47,50,6l). 
In 1951; Nelson et al. (35) a-13-!- later Bliss (6) and Bayliss (4) 
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determined the normal values for circulating 17-hydroxycorticosteroids, 
and more recently Bondy (7) has repeated this work with the analytical 
method used in this study. Much has been done to determine the ef¬ 
fects of ACTH on blood levels of hydrocortisone (4,5>15> 20,35^ *41.) and 
urinary levels of the steroid metabolites (44). There have been 
studies on the effects of hydrocortisone (l6,23,43), its role in elec¬ 
trolyte balance (30), amino acid metabolism (9>58)j and composition 
of urine (12,26,42,46,52), just to mention a few. The action of 
certain drugs and hormones on hydrocortisone metabolism has been the 
subject of other studies (l8,25,5l)^ along with the effects of hydro¬ 
cortisone on the function of other hormones (38)* 
In 1952, Nelson et al. (36) gave 200 mg. of oral hydrocortisone 
to humans and noticed a rise in the blood level, which fell to normal 
in eight hours. They also observed similar effects after intra¬ 
muscular injections of ethanolic solutions of hydrocortisone. 
Richards and Sweat (45) observed a consistent rise to about 50 ug. 
percent in 45 to 60 minutes after the oral administration of 50 mg. 
of hydrocortisone, and Haynes (25) gave 50 mg. orally and noticed 
a three hour peak and a five hour fall to normal. In all of these 
experiments the route of administration required an unmeasured 
amount of time for absorption which introduced a large variable. 
Eik-Nes (20) noticed after ACTH induced an elevation of the blood 
17-hydroxycorticosteroid concentration it decreased at a rate pro¬ 
portional to the concentration. Using C-l4 labelled hydrocortisone 
as a tracer dose, Hellmann et al., in 195^+ (26) gave a total of 
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100 mg. of hydrocortisone intravenously over a thirty minute period 
and studied the rate of disappearance of labelled carbon from the 
blood and its excretion in the urine, feces, and expired air. The 
percentage of excretion of C-l4 was constant with time, no matter 
how much carrier hydrocortisone was used. Fifteen minutes after 
the infusion was stopped only 13 percent of the radioactivity was 
present as free hydrocortisone. In 1954, Brown et al. (ll) gave 
intravenous hydrocortisone, 1 mg. per Kg. over a thirty minute period, 
and found that after one hour the plasma 17-hydroxycorticosteroid 
level fell exponentially. Eik-Nes et al. (2l) gave 50 mg. of hydro¬ 
cortisone intravenously in a two minute period and derived a mean 
curve from which a half-life of about two hours can be calculated. 
Done (19) studied the half-life of hydrocortisone after intravenous 
injection in normals and patients with rheumatic fever and found 
a range in normals of 60 to 133 minutes with an average of 90 min¬ 
utes. The disappearance curve after the administration of 1 mg. per 
Kg. over a thirty minute period was proportional to the concentration 
in the plasma, thus appearing to be a first order reaction. Sayers' 
group (53) showed an initial period of rapid removal from the blood, 
immediately after the infusion, followed by a period of disappearance 
at a rate proportional to concentration, with half-lives of 1.3 to 
2.3 hours in one normal and two Addisonian patients. Peterson et al. 
(39) found a half-life in 20 normals of 114 - 6.5 minutes with a 
range of 90 to 130 minutes after administration of 50 to 500 mg. over 
about a thirty minute period. 
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In this project we have been interested in studying the intimate 
mechanics of the disappearance of intravenous hydrocortisone. Dis¬ 
appearance curves of hydrocortisone have been determined, both after 
acute massive levels in Part I, and during slow injections at rates 
which permitted the establishment of equilibrium at plasma hydrocorti 
sone concentrations found clinically in Part II. Because we have 
administered all the hydrocortisone at one time in Part I, we have 
been able to study the early period of rapid removal from the plasma, 
which has not been done in previous experiments. By administering 
a smaller dose over a long period and at a constant known rate we 
have been able to reach a time when the amount of hydrocortisone 
entering the plasma equals the amount leaving it. Therefore the 
decay at this time should equal that of hydrocortisone at equilibrium 
We have also attempted to estimate the volume of distribution of 
hydrocortisone in the body assuming that it is at a constant con¬ 
centration throughout its distribution. 
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MATERIALS AMD METHODS 
All subjects were healthy male medical students between the ages 
of 21 and 25 years, without evidence of serious disease, or history 
of hepatic, renal, or endocrinological abnormality. Studies were 
started between 8:30 and 9*30 A.M. The subjects were ambulatory, 
but were kept at a low level of physical activity. They were on 
normal diets throughout the experiment, and all understood the nature 
of the procedure. Five subjects were used in each part, and those 
who participated in Part I were not used in Part II. 
Heparinized blood samples were centrifuged immediately upon 
withdrawal and except in a few cases were extracted the same day. 
On occasion it was necessary to freeze the plasma for a few days 
prior to extraction. The plasma samples were analyzed by the method 
of Bondy et al. (7), a brief description of which follows. 
Appropriate duplicate quantities of plasma were mixed with 0.5 
ml. of 1.0 normal NaOH per 20 ml. of plasma, and with 1.0 ml. of 
C-l4 labelled hydrocortisone, with about 400 counts per minute. 
They then were extracted three times with 20 ml. of freshly dis¬ 
tilled chloroform and transferred to boiling flasks, with a small 
well at the bottom, dried down, and the dried extract washed into 
the well with chloroform. The well contents were then spotted on 
Whatman's no. 1 chromatography grade filter paper by using a few 
drops of chloroform as the transferring solvent. The paper was 
then placed in a Bush toluene-75 percent methanol chromatography 
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system, allowed to equilibrate overnight and then having a toluene 
mobile phase rim with gravity for four hours. The hydrocortisone 
spots were identified by taking a contact picture with a short wave 
ultra violet light, "Mineralight" model SL 2537 > for one second at 
a distance of nine feet. The spots were then cut out in parallel 
with a paper blank of identical size just distal to the hydrocorti¬ 
sone spot and were eluted in 3 ml. of absolute ethyl alcohol at 40 
degrees centigrade for one hour. Three tenths ml. aliquotes were 
dried down in duplicate fluorimetry tubes and a standard curve made 
up with 0.5, 10, and 2.0 ug. of pure hydrocortisone. One half ml. 
of 0.30 to 0.35 normal potassium tert-butoxide base in tert-butyl 
alcohol was added to each tube, and the fluorescence allowed to 
develop for one hour, then read on a Farrand fluorimeter, using a 
Corning No. ^Q60 primary filter and a Corning No. 24l8 secondary 
filter. One ml. aliquots were dried down and dissolved in 15 ml. 
of solvent made up with 4.0 gm. of 2,5-diphenyloxazolarri.0.03 gm. 
of 1,4-di £2-(5 phenyloxazol]] benzene per liter of toluene and 
then counted in a Technical Measurement Corporation liquid phos¬ 
phor counter, LP-2A, and percent radioactive recovery calculated 
by comparing the number of counts per sample with a standard that 
had been measured out on the day of the extraction procedure. The 
percent recovery was used to correct for hydrocortisone lost during 
the analytical procedure. The corrected value was then translated 
into micrograms percent. The calculated standard deviation between 
duplicate samples is £ 10 percent. 
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EXPERIMENTAL PROCEDURES 
Part I.: A control Hood, specimen was drawn using a no. 19 
needle, and 100 mg. of hydrocortisone in 20 ml. of 50 percent alcohol 
(Upjohn) which had heen diluted up to 150 ml. with 5 percent glucose 
in water, was injected over a five minute period through the same 
needle. Blood samples were taken at 15, 60, 150, 300, and 420 min¬ 
utes, In two subjects samples were taken every fifteen minutes for 
the first hour and every twenty minutes for the second hour. The 
total amount of blood drawn was 320 ml. 
Part II.: After a control blood specimen was drawn, an infus¬ 
ion of hydrocortisone in 500 ml. of 5 percent glucose (Merck) was 
injected at approximately 300 ug. per minute, using a constant 
infusion pump and infusing through a no-. 19 needle. Thereafter 
blood was withdrawn from the opposite arm at 60, 165, l80, 300, and 
480 minutes. The total amount of blood drawn was 360 ml. After 
withdrawal of the l80 minute sample the infusion was stopped and 
the solution run through the pump and needle into a 100 ml. volu¬ 
metric flask for ten minutes. The flask was then filled to volume 
with distilled water, and an appropriate aliquot was extracted with 
chloroform three times, the chloroform dried down, the residue dis¬ 
solved in 6 ml. absolute ethyl alcohol, and read on a Beckman spectro¬ 
photometer at a wave length of 242 mji to determine accurately the 
amount of hydrocortisone infused over a ten minute period. 
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CALCULATIONS 
Part I.: Curves were plotted on semi-logarithmic graph paper. 
At the time of the first post infusion sample it was assumed that 
the adrenal gland was no longer secreting hydrocortisone and that 
the amount of endogenous hydrocortisone present was relatively small 
so that the plasma level was almost totally due to exogenous hydro¬ 
cortisone. If the volume of distribution of the steroid is constant 
and the rate of disappearance from the plasma is proportional to 
concentration (21) the rate is represented by the equation: 
= kc 
dt 
Where cv is the concentration in the volume of distribution, 
"t" is time, and "k" is the percent of steroid disappearing per unit 
time. By integrating we get: 
„ _ n -kt 2. c - Co e 
Where "Co" is the concentration at time zero. 
Part II.: Curves were plotted on linear and semi-logarithmic 
graph paper. The same assumptions were made regarding the endogenous 
hydrocortisone as in Part I. Since hydrocortisone was being added 
to the system at a constant rate the change of concentration assum- 
no loss would be: 
3. dc . p 
dt ~ v 
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Where € is rate of infusion and "v" the volume of distribution. 
When the rate of disappearance of the steroid is taken into account 
(equation 2), the net increase in concentration may he represented by: 
4- n = _ ice 
dt v 
If the concentration of material was zero at time zero,, then 
integrating: 
5- c = X. (1 - <Tkt) 
kv 
When "t" reaches infinity "c" reaches an asymptote: 
6* c = ± 
kv 
f is a known constant and the values for known at different 
times. Substituting these values in equation 5) "v" and "k" can be 
derived, and by equation 6, "v" can be derived when "c" has reached 
the asymptote. The descending curve is analyzed by equation 2. 
We calculated the elimination of endogenous hydrocortisone in 
Parts I and II from equation 2, assuming that the disappearance of 
endogenous hormone proceeded at the same rate as exogenous hydrocor¬ 
tisone when at equilibrium (26). By subtracting the calculated en¬ 
dogenous curves from the total one obtains an approximation of the 
exogenous curves (figures 1,2, and 3)» 
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RESULTS 
Table 1 represents the levels obtained after the acute injection. 
The concentrations differ widely about the mean, but each falls on a 
smooth curve-. Figure 1 represents the mean graph of Part I. During 
the first 150 minutes the rate of disappearance from the plasma de¬ 
celerates fairly evenly and forms a curve on semi-logarithmic paper. 
It can be represented by two arbitrary straight lines which approximate 
the average rates of disappearance during those periods. Thus during 
the first 60 minutes there is a rapid disappearance from the plasma 
at an average rate of 1.84 percent per minute. Over the next 90 min¬ 
utes the disappearance averages 1.20 percent per minute. For the next 
270 minutes the disappearance rate remains constant at Q« 51 percent 
per minute with a mean half-life ofj 138 minutes and a range among our 
subjects of 58 to l6l minutes. 
Frequent samples were taken during the first two and a half hours 
in two subjects. The results are shown in Table 2. Because of the 
very high exogenous levels during this early part of the curve it is 
not necessary to subtract the endogenous levels. During this time 
there is a rapid fall, especially in subject JS where the concentra¬ 
tion falls precipitously and then rebounds upward to approach the 
mean curve. The magnitude of this fall is much greater than experi¬ 
mental error, since the standard deviation for this part of the 
curve was - 8.5 percent. The number of subjects is too small and 
the results too individualized to permit calculation of relevant 
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half-lives; however, the data demonstrates the rapidity of the fall 
and un predictability of the disappearance curves immediately after 
a large hydrocortisone injection. If one assumes that the plasma 
volume is 4 percent of body weight, in these experiments 94.0 per¬ 
cent of the administered dose had disappeared from the plasma after 
15 minutes, 97*4 percent at the end of 60 minutes, and 99«1 percent 
after 150 minutes. 
The plasma hydrocortisone level fell below the initial endog¬ 
enous concentration five to seven hours after the acute hydrocorti¬ 
sone injection. 
Table 3 represents the results obtained with the constant in¬ 
fusion in Part II. Here, as in Part I, there is a wide individual 
variation from the mean. The values at 165 minutes and l80 minutes 
are so similar for any given subject that it has been thought valid 
to average them and consider that the curve has reached its asymptote 
during this period. The equilibrium concentrations range from 23.6 
to 62.6 fig. percent. During the infusion the rate of utilization of 
hydrocortisone decreases constantly, leveling off during the final 
15 minutes toward a half-life of 172 minutes. During this 15 min¬ 
ute period, the volume of distribution averages ll6 percent of body 
weight. Figure 2 shows the calculated mean curve plotted on linear 
graph paper and the theoretical curve one would obtain if "k" were 
equal to that during the post infusion period, when it is constant, 
and if V is derived from equation 6, when "c" has reached the 
asymptote. This calculation for "v" comes out 186 percent of body 
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weight. In Part II the hydrocortisone disappears from the blood at 
constant rate of)0*57 percent per minute with a half-life of l12k 
minutes and an individual range of 93 to l4l minutes. During the 
infusion, 9^.7 percent of the administered hydrocortisone had dis¬ 
appeared from the plasma after 60 minutes and 97*9 percent after l30 
minute s. 
Pre-infusion 'levels in all subjects in Part II, except TT, are 
t 
above the normal range. Control samples at a later date are all 
within normal range. At the end of Part II, as in Part I, there is 
a dip in the plasma hydrocortisone level below the initial endogen¬ 
ous level. 
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DISCUSSION 
In these experiments after a period of equilibration hydrocorti¬ 
sone disappeared from the blood stream at a constant rate, with an 
average half-life of about 130 minutes. This confirms the observa¬ 
tions by Eik-Nes (20,2l), Brown (ll), Done (19), Sayers (53), and 
Peterson (39) previously referred to. This constant rate is due 
mainly to the activity of the liver since Tomizawa et al. (59) 
found hepatectomized rats did not metabolize hydrocortisone, and 
Brown (ll) showed that in patients with liver disease the disap¬ 
pearance rate of hydrocortisone was slowed proportional to the re¬ 
tention of bromsuphophthalein, but that the tetra-hydro metabolite 
of hydrocortisone was eliminated normally. Weichselbaum (64) showed 
a greatly diminished ability of the liver to conjugate hydrocorti¬ 
sone in severe stress where there is a high hydrocortisone level. 
Peterson (39) also found increased half-lives in all his patients 
with liver disease. 
Like Brown (ll) and Heilman (26), we found that initially re¬ 
moval of hydrocortisone from the blood is very rapid. If the data 
presented by Eik-Nes (2l) for individual curves is plotted on semi- 
logarithmic paper each curve falls more rapidly between the first 
and second hour than during the remainder of the tine. During the 
first hour the hydrocortisone was leaving the plasma almost four 
times as fast as when at equilibrium. During this period, most of 
the hydrocortisone disappearing from the plasma was probably entering 
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the liver, for Braellov et al. (10) shoved that JO percent of infused 
hydrocortisone vas quickly hound hy the mouse's liver, hut some of 
the steroid probably vent elsevhere. Tomizava et al. (59) shoved a 
rapid ten minute fall of hydrocortisone levels after infusion in 
hepatectomized rats, folloved hy a period during vhich a high level 
vas maintained. They attributed the ten minute fall to a period of 
equilibration after vhich any further decline vas due to liver metab¬ 
olism. Leven et al. (32) attributed this rapid disappearance phase 
to binding by tissues, and shoved that in this property kidney, 
spleen, and liver vere very active, vhereas diaphragm and fat vere 
less so. Of all these tissues, hovever, the liver vas the only one 
that metabolized hydrocortisone to any significant degree. They 
postulated that bound steroid vas in equilibrium and freely exchange¬ 
able vith plasma steroid. There is also in vitro evidence of rapid 
binding of hydrocortisone by various proteins (22). The early rapid 
disappearance is probably due to many of these factors. We might 
postulate tvo general equations: 
1. Free plasma hydrocortisone and receptor proteins^: —" —•-TTr^ 
bound hydrocortisone. 
2. Free plasma hydrocortisone —-^ reduced hydro¬ 
cortisone. 
Where plasma is loaded vith hydrocortisone, reaction 1, vhich 
is normally at equilibrium, must shift to the right. As the products 
on the right accumulate up reaction 1 slovs dovn until equilibrium 
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is again attained. Meanwhile reaction 2 goes on at a rate propor¬ 
tional to plasma concentration. Initially, therefore, the plasma 
concentration reflects hoth reactions, "but during the later part of 
the experiment reaction 1 is at equilibrium and the plasma concen¬ 
tration curve represents reaction 2. Peterson (39) sites evidence 
for a specific liver enzyme which acts on hydrocortisone, and not 
other steroids, to reduce the A k double bond. This is the limit¬ 
ing reaction the dihydrohydrocortisone being quickly reduced by a 
non-specific enzyme to tetrahydrohydrocortisone. 
In Part II the mean curve comes to equilibrium sooner than was 
predicted. It might be postulated that hydrocortisone is at equili¬ 
brium with a smaller space and does not yet fill the calculated "v" 
with "t” infinity. We found the experimental volume based on the 
rising curve to be less than the theoretical volume. The calcula¬ 
tions predicting the plasma hydrocortisone curves during constant 
loading assume that the volume of distribution and the velocity 
constant "k" do not change. Actual observation, however, showed 
that either "v" or "k" or both changed constantly during the infus¬ 
ion. This may be, in part, because the concentration of hydrocor¬ 
tisone is not equal in the various body fluid compartments (3,^+9)* 
From the two equations suggested above, one might anticipate that 
the value of "k" would be high early in the infusion, and fall to¬ 
ward a constant value as equilibrium of equation 1 is reached. This 
was, infact, observed. One might also predict that the hydrocorti¬ 
sone binding of proteins of equation 1 might be able to hold the 
steroid in higher concentration than does the plasma (22,3^-). 
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This deduction is supported by our calculations that 'V at equilib¬ 
rium is greater than body volume, indicating that in some tissues 
hydrocortisone is more concentrated than in plasma. Similar calcu¬ 
lations on the data from Tomizawa's hepatectomized rat experiment 
(59)^ where almost no hydrocortisone is being destroyed also show 
"v" to be greater than body volume. Peterson (39)- estimated a hydro¬ 
cortisone space that equaled body weight. Thus the concept of volume 
of distribution for hydrocortisone at a constant concentration is not 
a valid one. 
The low values for hydrocortisone found at the end of the ex¬ 
periment can be interpreted as due to suppression of ACTH by exog¬ 
enous hydrocortisone with a lag period after most of the hydrocorti¬ 
sone has been metabolized, leaving an adrenal that has had no stimu¬ 
lation for a few hours. There must be many unrecognized variables 
which act upon the distribution and disappearance of hydrocortisone 
to account for the wide range of individual values. Pre-injection 
steroid concentrations were frequently elevated in subjects later 
proven to be normal suggesting that the test situation itself may 
alter in some way either the rate of endogenous secretion or rate 
of utilization of the hormone. The detailed one hour curves in 
Part I indicate that these reactions may be multiply influenced, 
and may depend upon body functions controlled by other systems 
which alter the rate of equilibrium or degradation. In some in¬ 
dividuals the initial fall is much steeper and the period of degra¬ 
dation more gradual. Post-infusion values are much higher in some 
individuals than others and not inversely related to body size. 

l8 
Therefore the fact that the mean disappearance curves are so similar 
in two sets of subjects has only significance in showing that the 
disappearance of hydrocortisone after reaching equilibrium in the 
serum and at clinical levels is proportional to the concentration 
of hydrocortisone but varies greatly from one individual to the next. 
The disappearance rate of exogenous hydrocortisone was remarkably 
constant in the two groups with different doses and rates of infus¬ 
ion. Peterson (39) showed that the rate of disappearance remains the 
same in an individual whether 50 or 500 mg. of hydrocortisone are 
infused. Thus at levels of hydrocortisone seen in Cushing's disease 
(l4,37.> 56), pregnancy (47), during surgery (50), rheumatic fever (29), 
life threatening states and other clinical situations (37^54) there 
is a constant rate of disappearance in normals. The frequency of 
such a rise as part of the body reaction to disease and stress sug¬ 
gests that the mechanism of increased hydrocortisone levels may be 
similar in these unrelated states. Studies cited previously indicate 
that hydrocortisone degradation is slowed down in certain conditions 
due to decreased liver metabolism. However, that this is not always 
the mechanism of an increased level was shown by Tyler et al. (60) 
who found high concentrations in elderly normals who had normal 
rates of breakdown by the liver. They postulated a contracted vol¬ 
ume of distribution with a normal output. In carcinoma of the adrenal 
neither liver metabolism or hydrocortisone space are responsible for 
the high level, which is probably due to the autonomy of the neoplasm 
and uncontrolled secretion. In stress the hydrocortisone levels are 
higher than can be accounted for by maximum ACTH production for 
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large amounts of ACTH cannot stimulate the normal adrenal to produce 
these levels (6l). Thus the question of what controls hydrocortisone 
levels in the blood is far from answered. There may be many factors, 
some of which might include changes in hydrocortisone space and 
binding power of tissues; a change in the reactivity of the adrenal 
cortex to ACTH under different conditions; rate of autonomous secre¬ 
tion by the adrenal cortex; decreased peripheral utilization; and 
diminished liver metabolism. All of these must be studied before 
hydrocortisone metabolism can be well understood. 
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SUMMARY 
1. Some of the highlights in the history of plasma corticosteroid 
chemical analysis are cited. Some previous experiments involv¬ 
ing the effects of hydrocortisone, its metabolism, and rates of 
disappearance from the plasma are reviewed. 
2. One hundred mg. of hydrocortisone was injected intravenously 
in five minutes into healthy subjects and the disappearance of 
the steroid from the plasma was followed. The rate of removal 
was rapid at first, gradually decreasing to about one-fourth of 
the original rate at two and one-half hours, after which it 
remained constant with a mean half-life of |l3G I minutes. 
3. In a second set of experiments a constant infusion of 300 J*g. 
per minute was given. At three hours an equilibrium was reached 
where the amount leaving the plasma equaled the amount entering. 
The post infusion curve was plotted and a mean half-life of 1121; 
minutes was found. The volume of distribution at the plasma 
concentration at equlibrium was ll6 or 187 percent of body 
weight was found, depending on the method of calculation. 
4. Large individual variations were noted in these experiments. 
5. Levels a few hours after infusion were lower than those found 
before. Pre-infusion levels were elevated above normal in some 
of the subjects later proven to be normal. 
6. The results suggest that hydrocortisone may leave the plasma 
in two general ways: by a reversible system in which the 
steroid is bound in high concentrations to tissue proteins, 
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and an irreversible system whereby hydrocortisone is permanently re¬ 
moved from the plasma. The early part of the disappearance curve is 
greatly influenced by the reversible binding of the steroid, whereas 
the late portion of the curve reflects a first order metabolic process, 
presumably occurring chiefly in the liver. 
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PLASMA HYDROCORTISONE IEVELS AFTER ACUTE INTRAVENOUS INJECTION OF HYDROCORTISONE 
Part I: Uncorrected levels in jig. percent. 
Time in minutes 
Subject Weight 0 15 60 150 300 420 
CH 92.9 Kg. 10.0 l4o 84.0 14.5 2.5 8.2 
AD 75.0 9.4 205 73.8 31.1 15.6 4.0 
JC 71.8 4.5 179 63.O 37.5 19.5 12.0 
JS 61.3 22.5 227 70.9 49.5 25.O 10.0 
AH 72.8 18.9 314 197.0 39.0 21.0 8.7 
MEAN^SD 74.8 13. i4 .2 213^9.4 97-7^6.‘ > 35.5-10.6 16.7^3.5 8.6-3.9 
Kean endogenous levels in percent 
13.1 12.1 9.6 6.0 2.8 1.5 
Mean exogenous levels, corrected for endogenous decay, 
in jog. percent 
0 201 88.1 29.5 13.9 7.1 
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TABLE 2 
PLASMA HYDROCORTISONE IEVEIS DURING THE FIRST 150 MINUTES AFTER ACUTE 
INTRAVENOUS INJECTION 
Part I.: Uncorrected levels in jig. percent 
Time in minutes 
Subject 15 30 45 ^0 80 100 120 150 
JS 227 136 42.2 70.9 42.2 83.3 55.5- 49.5 
AH 314 219 188.0 197.0 136.8 82.1 56.0 39.0 
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TABLE 3 
PLASMA HYDROCORTISONE LEVELS DURING AND AFTER CONSTANT INFUSION OF HYDROCORTISONE 
Part H: Uncorrected levels in pg. percent 
Time in minutes 
Subject Weight Inf. rate 0 60 165“' 180 300 480 
JK 74.0 Kg. 327 jig./min 22.9 62.2 69.5 64.3 33-7 15.4 
GE 77.6 371 21.6 37.2 38.8 37.8 l8.4 4.3 
RW 77-3 231 21.0 33.3 45.0 49.0 20.8 7.9 
AH 88.7 378 15.0 24.0 25.8* 25.8 20.0 4.0 
TT 95-5 227 7.2 23.6 36.2 28.8 15.2 5.5 
MEAN-SI1 83.0 301 17.5-4.2 36.1^4.2 43.1^6.3 4i.i^4.5 21.6^3.8 7.4^1.6 
Mean endogenous levels in ug. percent 
17-5 12.6 7.0 6.5 3.3 1.2 
Mean exogenous levels, corrected for endogenous decay, 
in jig. percent 
0 23.5 35.2** 18.3 6.2 
* Because 
tained. 
average 
of error in analysis of the 165 minute sample there was no value oh- 
The l80 minute value is used in order to preserve the mode of the 
curve. 
** The mean of the 163 and l80 minute values. 

FIGURE 1 
MEAN CURVES AFTER ACUTE INTRAVENOUS INJECTION OF HYDROCORTISONE. 
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FIGURE 2 
MEAN CURVES DURING AND AFTER CONSTANT INFUSION OF HYDROCORTISONE 
(linear graph paper) 
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FIGURE] 3 
MEAN CURVES DURING AND AFTER CONSTANT INFUSION OF HYDROCORTISONE 
(semi-logarithmic graph paper) 
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